The Psychosocial Challenges Facing Multi Drug Resistance Tuberculosis Patients: A Qualitative Study

Elangovan, Thiruvalluvan; Thomas, Beena; Chandra, Shaleen; Sellappan, Senthil; Muniyandi, Malaisamy; Watson, Basilea

doi:10.3126/saarctb.v14i1.17724

Cited by 7 publications

(15 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These studies broadly focused on socioeconomic risk factors, social issues, and financial issues. Eleven (11) of the articles reviewed focused on only social aspects, four (4) only on financial/ economic issues and five (5) articles covered both social and economic aspects. Of the selected articles, with the updated search one (1) was a cross-sectional study focusing on social aspects and a systematic review covering both social and economic aspects.…”

Section: Study Setting Of Reviewed Articlesmentioning

confidence: 99%

“…Available data reveals that between 36,000 and 44,000 MDR-TB cases were reported in the AFRO Region in 2016 and of these, 15% of new MDR-TB patients were found to have RR [3]. Empirical evidence indicates that DR-TB is a multifaceted illness with expensive treatment regimens, toxic medications and long duration of treatment creating a substantial financial burden on the health system [10,11]. Consequently, socioeconomic status, job loss, overpopulation, poor hygiene, immunocompromising illnesses and malnourishment have been identified as risk factors that influence this disease burden hence it is commonly referred to as the disease of the poor [12].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review

2021

View full text Add to dashboard Cite

Background Drug-resistant TB (DR-TB) remains a public health concern due to the high morbidity and mortality rates from the disease. The DR-TB is a multifaceted illness with expensive treatment regimens, toxic medications and most often the long duration of treatment constitutes a substantial financial burden on both infected patients and the health system. Despite significant research advances in the diagnosis and treatment, there is a paucity of synthesized evidence on how socio-economic factors are associated with DR-TB. This review aims to address this gap by synthesizing available evidence and data on the common socio-economic drivers of DR-TB infection in Africa. Methods A systematic search was conducted on PUBMED and Google Scholar databases from January 2011 to January 2020 using Joanna Briggs Institute’s scoping review approach. An updated search was conducted on 21 September 2020. The eligibility criteria only included systematic reviews and studies with quantitative research methods (cross-sectional, case-control, cohort, and randomized-control trials). Studies conducted in Africa and focusing on socio-economic factors influencing DR-TB burden in African countries were also considered. Data was extracted from all the studies that met the eligibility criteria based on the study’s objectives. Results Out of the 154 articles that were retrieved for review, 20 abstracts of these articles met all the eligibility criteria. Of the 20 articles, 17 quantitative and 3 reviews. Two additional articles were found eligible, following the updated search. The following themes were identified as major findings: Social and economic drivers associated with DR-TB. Substance abuse of which, stigma and discrimination were the prominent social drivers. Economic drivers included poverty, financial constraints because of job loss, loss of productive time during hospital admission and treatment costs. Conclusion This review has highlighted which socio-economic factors contribute to DR- TB This is relevant to assist DR-TB management program and TB stakeholders in different settings to address identified socio-economic gaps and to reduce its negative impact on the programmatic management of DR TB. Therefore, redirecting strategies with more focus on socio-economic empowerment of DR-TB patients could be one of the innovative solutions to reduce the spread and eliminate DR-TB in Africa.

show abstract

Section: Study Setting Of Reviewed Articlesmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review

2021

View full text Add to dashboard Cite

show abstract

“…10 The negative impacts of TB encompass physical, psychological, social, and financial effects. 11–13 Thus, TB is associated with anxiety and depression symptoms, and as a result of hospitalization, stigma, and challenges in supporting family life, patients develop social isolation and fail to get the social support that is essential to keep healthy status. 14 Furthermore, the direct impact of RR/MDR-TB on the quality of life extends to patients and their families.…”

Section: Introductionmentioning

confidence: 99%

Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients

Araia¹,

Berhane²,

Mebrahtu³

et al. 2021

PROM

View full text Add to dashboard Cite

Background Despite the negative impact of tuberculosis (TB) on patients’ quality of life, TB control programs focus on biological and clinical parameters to manage and monitor TB patients. In our setting, patients’ perception of their experience with TB and the impacts of TB on patients’ physical, mental, and social wellbeing remain unknown. Objective The objective of this study was to evaluate the health-related quality of life (HRQOL) among rifampicin/multidrug-resistant TB (RR/MDR-TB) in comparison to drug-susceptible TB (DS-TB) patients in Eritrea. Methods A cross-sectional study was conducted in RR/MDR-TB and DS-TB patients under treatment. Anonymized data collected using the WHOQOL-BREF questionnaire were analyzed using SPSS version 23. Frequency, mean and standard deviation were used to describe the data. Mean group score comparison and relationship between variables were assessed using t -test. Domain score was calculated with a mean score of items within each domain and scaled positively, a higher (increasing) score denoting a higher quality of life. Internal consistency was measured using Cronbach’s alpha and statistical significance was set at p < 0.05. Results A total of 92 patients (46 RR/MDR-TB and 46 DS-TB) participated in the study. Environmental (40.63 ± 10.72) and physical domains (61.80 ±17.18) were the two most affected domains in RR/MDR-TB and DS-TB patients, respectively. The psychological domain was the least affected domain in RR/MDR-TB (48.28 ± 20.83) and DS-TB patients (76.63 ±15.32). RR/MDR-TB patients had statistically lower mean scores in all domains than DS-TB patients. Conclusion HRQOL was impaired in both groups, but RR/MDR-TB patients had a worse health-related quality of life.

show abstract

“…These studies broadly focused on socio-economic risk factors, social issues, and nancial issues. Eleven (11) of the articles reviewed focused on only social aspects, four (4) only on nancial/ economic issues and ve (5) articles covered both social and economic aspects. Of the selected articles, with the updated search one (1) was a cross-sectional study focusing on social aspects and a systematic review covering both social and economic aspects.…”

Section: Summary Of the Studies Reviewedmentioning

confidence: 99%

Socio-economic drivers of Drug-Resistant Tuberculosis in Africa: A Scoping Review

Cannon

Oladimeji

Goon

2020

Preprint

View full text Add to dashboard Cite

Background: Drug-resistant TB (DR-TB) remains a public health concern due to the high morbidity and mortality rates from the disease. The DR-TB is a multifaceted illness with expensive treatment regimens, toxic medications and most often the long duration of treatment constitutes a substantial financial burden on both infected patients and the health system. Despite significant research advances in the diagnosis and treatment, there is a paucity of synthesized evidence on how socio-economic factors are associated with DR-TB. This review aims to address this gap by synthesizing available evidence and data on the common socio-economic drivers of DR-TB infection in Africa.Methods: A systematic search was conducted on PUBMED and Google Scholar databases from January 2011 to January 2020 using Joanna Briggs Institute’s scoping review approach. An updated search was conducted on 21 September 2020. The eligibility criteria only included systematic reviews and studies with quantitative research methods (cross-sectional, case-control, cohort, and randomized-control trials). Studies conducted in Africa and focusing on socio-economic factors influencing DR-TB burden in African countries were also considered. Data was extracted from all the studies that met the eligibility criteria based on the study’s objectives.Results: Out of the 154 articles that were retrieved for review, 20 abstracts of these articles met all the eligibility criteria. Of the 20 articles, 17 quantitative and 3 reviews. 2 additional articles were found eligible, following the updated search. The following themes were identified as major findings: Social and economic drivers associated with DR-TB. Substance abuse of which, stigma and discrimination were the prominent social drivers. Economic drivers included poverty, financial constraints because of job loss, loss of productive time during hospital admission and treatment costs.Conclusion: This review has highlighted which socio-economic factors contribute to DR- TB This is relevant to assist DR-TB management program and TB stakeholders in different settings to address identified socio-economic gaps and to reduce its negative impact on the programmatic management of DR TB. Therefore, redirecting strategies with more focus on socio-economic empowerment of DR-TB patients could be one of the innovative solutions to reduce the spread and eliminate DR-TB in Africa.

show abstract

The Psychosocial Challenges Facing Multi Drug Resistance Tuberculosis Patients: A Qualitative Study

Cited by 7 publications

References 8 publications

Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review

Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review

Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients

Socio-economic drivers of Drug-Resistant Tuberculosis in Africa: A Scoping Review

Contact Info

Product

Resources

About